KeniRAlexanderANayakPGMudgalJNandakumarK.COVID-19: emergence, spread, possible treatments, and global burden. Front Public Health. 2020;8:216. doi:10.3389/fpubh.2020.00216
3.
BrueggemannABJansen van RensburgMJShawD, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360-e370. doi:10.1016/s2589-7500(21)00077-7
4.
ZimmerAKlintonJSOga-OmenkaC, et al. Tuberculosis in times of COVID-19. J Epidemiol Community Health. 2022; 76(3):310-316. doi:10.1136/jech-2021-217529
5.
AznarMLEspinosa-PereiroJSaboritN, et al. Impact of the COVID-19 pandemic on tuberculosis management in Spain. Int J Infect Dis. 2021;108:300-305. doi:10.1016/j.ijid.2021.04.075
Vanden DriesscheKMahloboPZVenterR, et al. Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?Lancet Respir Med. 2021;9(4):340-342. doi:10.1016/s2213-2600(21)00020-5
8.
PaiMKasaevaTSwaminathanS.COVID-19’s devastating effect on tuberculosis care—a path to recovery. N Eng J Med. 2022;386(16):1490-1493. doi:10.1056/nejmp2118145
9.
CilloniLFuHVesgaJF, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28:100603. doi:10.1016/j.eclinm.2020.100603
10.
ZanaaAParamitaSAErdeneeO, et al. Childhood tuberculosis in Mongolia: trends and estimates, 2010-2030. Tohoku J Exp Med. 2022;257(3):193-203. doi:10.1620/tjem.2022.J034